NAN Nanoscience

TIDMTMZ

RNS Number : 6200A

Toumaz Limited

30 September 2015

30 September 2015

Toumaz Limited

Amendment to terms of Director's share options

Toumaz Limited (AIM: TMZ) announces that on 29(th) September 2015, the Company's Board of Directors has formalised an undertaking made by the previous Board that 1,683,835 fully vested options with an exercise price of 6.94p granted to Prof C Toumazou on 30 September 2005 and due to expire on 30 September 2015 have been extended by 12 months to expire on 30 September 2016

 
 Name of contact                Jonathan Apps 
-----------------------------  --------------------- 
 Telephone number of contact    +44 (0) 20 7391 0630 
-----------------------------  --------------------- 
 

About Toumaz (www.toumaz.com)

Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for healthcare and consumer audio. The company has two divisions, Sensium Healthcare and Frontier Silicon. Sensium Healthcare develops wireless solutions for patient monitoring. Frontier Silicon provides chips, modules and software for digital audio devices.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCBLGDCGDDBGUC

(END) Dow Jones Newswires

September 30, 2015 03:00 ET (07:00 GMT)

Nanoscience (LSE:NAN)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025

Nanoscience (LSE:NAN)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025